DiaMedica Therapeutics Announces Late Breaking Data from REDUX Phase 2 Trial to be Presented at ASN Kidney Week 2021Business Wire • 10/18/21
DiaMedica Therapeutics Announces Fast Track Designation Granted to DM199 for the Treatment of Acute Ischemic StrokeBusiness Wire • 09/30/21
DiaMedica Therapeutics Initiates Pivotal Trial of DM199 for the Treatment of Acute Ischemic StrokeBusiness Wire • 09/13/21
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/12/21
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2021 Financial ResultsBusiness Wire • 08/11/21
DiaMedica Therapeutics to Report Second Quarter 2021 Financial Results and Provide a Business Update August 12, 2021Business Wire • 08/05/21
DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology ConferenceBusiness Wire • 07/28/21
DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of DirectorsBusiness Wire • 07/15/21
DiaMedica Therapeutics Stock Slips On Mixed DM199 Data In Chronic Kidney Disease PatientsBenzinga • 06/29/21
DiaMedica Therapeutics Announces Positive Interim Results from Phase 2 REDUX Study in CKDBusiness Wire • 06/29/21
Is the Options Market Predicting a Spike in DiaMedica (DMAC) Stock?Zacks Investment Research • 05/26/21
DiaMedica Stock Gains On Green Signal To Start Pivotal DM199 Trial In Ischemic StrokeBenzinga • 05/17/21
DiaMedica Therapeutics Announces FDA Clearance of IND Application to Initiate Phase 2/3 Clinical Trial for DM199 for Acute Ischemic StrokeBusiness Wire • 05/17/21
DiaMedica Therapeutics Inc.'s (DMAC) CEO Rick Pauls on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/09/21
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial ResultsBusiness Wire • 05/05/21
DiaMedica Therapeutics to Report First Quarter 2021 Financials and Provide a Business Update May 6, 2021Business Wire • 04/28/21
DiaMedica Therapeutics to Participate in the B. Riley Securities' Neuroscience ConferenceBusiness Wire • 04/22/21
DiaMedica Therapeutics to Present Research at the National Kidney Foundation's 2021 Spring Clinical MeetingsBusiness Wire • 04/05/21